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CHAPTER I.

INTRODUCTION

Previous Research (Central Stimulation)

Grossman (I960) has found anatomically overlapping neural systems
in a circumscribed region of the lateral hypothalamus which participate
in the regulation of food and water intake can be separated on a neurochemical basis.

The hypothalamic feeding system, which corresponds to

the "feeding area" of Anand and Brobeck (1951) and to that area con
cerned with the activation of specific feeding mechanisms discussed
by Morgane (1961), was found to be selectively sensitive to adrenergic
stimulation.

The system regulating water intake was found to be under

cholinergic mediation.

The direct application of carbachol (a cholino

mimetic which is highly resistant to the action of cholinesterase) to
this region resulted in increased water intake.

This effect could be

abolished by pretreating the subject with atropine sulfate, an anti
cholinergic agent, prior to central stimulation (Grossman, 1962).
While the structures involved in water intake have been extended
by research involving the central application of pharmacological
agents, the specificity of the relationship between cholinergic activ
ity and drinking behavior has been maintained.

Grossman (1964a) found

that stimulation of the ventral amygdala with doses of less than 0.5/*g
of carbachol led to an increase in the response rate of rats trained
on a VI 4 minute schedule for water reinforcement.

Atropine was found

to decrease the response rate for water.
The administration of carbachol to the medial septal area leads
to the initiation of drinking behavior in sated rats, and to an

increase in water consumption by water-deprived rats (Grossman, 1964b).
The application of atropine to the same area resulted in decreased
water intake by deprived rats— a result that has not been confirmed
by later studies.

Levitt and Fisher (1966) found that subjects who

received atropine centrally as well as carbachol drank only 10$ as
much as did those subjects receiving carbachol alone.

However, the

central application of atropine had no effect on thirst induced by *
23 hours of water deprivation, a result they later replicated (Levitt
& Fisher, 196?).

The issue is further complicated by the finding

that while anticholinergic stimulation had no effect on deprivationinduced thirst when only water was present in the test cage, it did
have a slight depressant effect when both food and water were present
(Levitt, 1968).
Fisher and Coury (1962) have suggested that there is a •'medially
oriented, generalized Papez circuit" regulating thirst-related
behavior.

They obtained drinking behavior following the injection

of carbachol into the dorsomedial hippocampus (area of the dentate
gyrus), septal regions, area of the diagonal band, the reuniensmesial thalamic region, perifornical and preoptic regions, anterior
thalamus (anterodorsal and anteroventral nuclei), lateral hypothalamus,
mammillary-interpeduncular regions, and the cingulate cortex.

These

positive regions are all either a part of the original Papez circuit,
which includes the hippocampus, fornix, mammillary regions of the
hypothalamus, anterior nucleus of the thalamus, cingulate gyrus, and
again the hippocampus, or are closely associated with it.

Levitt and Fisher (1966) found that the application of a cholin
ergic antagonist to many of the limbic and diencephalic structures
(cholinergic stimulation of which leads to thirst) prevented drinking
in response to cholinergic stimulation of other parts of the system.
As stated above, however, the necessity for the functional integrity
of the entire system was not apparent in the case of deprivationinduced thirst.

This result may perhaps be due to peripheral feed

back mechanisms (including throat and mouth receptors, osmoreceptors,
etc.) that are active only during deprivation-induced thirst.

Input

from such receptors to central triggering mechanisms may serve to
allow the system to operate even though one or more of the components
are blocked.
The role of acetylcholine in drinking behavior can be further
specified,

Stein and Seifter (1962), finding a depression of cholin

ergic drinking with atropine pretreatment of the same site that received
cholinergic stimulation, concluded that the cholinergic thirst system
is a muscarinic system, a conclusion confirmed by Levitt (1969 ).
Stimulating several areas of the thirst system (including the lateral
septal nucleus, the anterior thalamic nucleus, the dorsal fornix, and
the anterior medial midbrain) prior to stimulation of the same or
another of these areas with carbachol, Levitt found that only antimuscarinic agents consistently blocked cholinergic thirst.

Atropine

sulfate, a muscarinic blocking agent, blocked cholinergic thirst
(blockage defined as the consumption of 3.9 ml or less in a one-hour
test period) in as much as 96$ of the tested -sites.

Scopolamine

hydrobrord.de, another muscarinic blocking agent, produced up to 100$
blockage of cholinergic thirst.

This result is consistent with find

ings that atropine tends to be a somewhat less potent antimuscarinic
agent in other physiological systems (Cullumbine, 196?).

Among those

agents which failed to produce consistent blockage of cholinergic
thirst were dihydro-/3-erythroidine (an anticholinergic neuromuscular
blocking agent) and hexamethonium (a ganglionic blocking agent).
Application of strychnine, a central nervous system stimulant which
has been found to be a cholinesterase inhibitor (Nachmansohn, 1938),
resulted in a 52$ blockage of cholinergic thirst.

Finally, those

chemicals which effectively blocked cholinergically-induced thirst
did so more consistently when placed at a site different from the
carbachol site than when the two chemicals were placed at the same
site.

This result is consistent with the cholinergic thirst hypothesis.

"When placed at a different site the test agent had only to block the
naturally occurring acetylcholine, while if the agents were both
placed at the same site the test agent had to block the carbachol as
%

well as any naturally occurring acetylcholine.
In summary, the results of studies using central stimulation tech
niques suggest the existence of an interconnected circuit which acts
in the expression of thirst and thirst-related behavior.

This circuit

contains the major structures proposed by Papez (1937) to be involved
in the expression of emotion, as well as several other closely inte
grated structures.

The data also strongly indicates that acetylcholine

acts as the primary transmitter agent in this circuit, and further

that this cholinergic system is specifically muscarinic.

Previous Research (Peripheral Administration)

The peripheral application of atropine and scopolamine has been
found to suppress eating as well as drinking behavior,

Stein (1963)

found that atropine (5 mg/kg) and scopolamine (.4- mg/kg) given i.p.
to food or water deprived rats significantly suppressed both food and
water intake.

The effect on water intake would appear to be dose-

related, since a dose magnitude of 2 ,5 mg/kg atropine failed to sig
nificantly suppress drinking.

However, doses of 1 mg/kg atropine did

produce significant suppression of eating.

Atropine methyl nitrate

and scopolamine methyl nitrate, quaternary analogs which cross the
blood-brain barrier only with difficulty, both failed to cause exten
sive thirst suppression although they did significantly suppress eating
at all dose levels.

VJhitehouse, Lloyd, and Fifer (1964) found that

both atropine sulfate and atropine methyl nitrate given to rats at a
dose level of 2 mg/kg severely impaired food intake during a two hour
feeding period following injection.
The suppression of food intake is felt to be a function of the
peripheral effects of cholinergic attenuation, and not to be due to
central activity (for a discussion of the pharmacology of atropine and
scopolamine, see Appendix I).
interpretation.

Several lines of evidence suggest this

First, the quaternary compounds are slightly more

potent in their suppressive effects than are the centrally active ter
tiary compounds, a result which is in accord with the peripheral activ
ities of these compounds (Goodman & Gilman, 1965 ).

Further, Keehn and

Nagai (1969) found that trihexyphenidyl (Artane), an anticholinergic
which causes only mild dryness of the mouth and throat, suppressed the
water consumption of rats under the influence of schedule-induced poly
dipsia, but did not influence the number of food reinforcements consumed
by the subjects.
The data from studies of the effects of atropine and scopolamine on
liquid reinforced behavior suggest that their effects are a compound
function of the dose level, the number of drug administrations, and the
reinforcement schedule employed,

Herrnstein (1958) trained food deprived

rats to respond on a multiple schedule containing four components:

FI 5

minutes, S^, Sidrnan avoidance, and another SA. Reinforcement was 0,3 cc
sweetened condensed milk, and scopolamine was given at dose levels of
.05, .1, .2, .4, ,8, and 1.6 rag/kg.

The FI component showed a decreased

J

response rate with doses at or greater than ,1 mg/kg.

The FI quarter-

life (the amount of time it takes for the subject to emit ^ of the total
interreinforcement responses— -a measure of FI scalloping) was found to
be inversely related to dose magnitude.

The

and avoidance response

rates showed an inverted U-shaped relation to dose magnitude.

Finally,

one subject showed progressively decreasing effects following repeated
administrations of .1 mg/kg scopolamine.

While •'food” was used as the

reinforcer, interpretation of the decreased response rate on the FI com
ponent must await further information on the effect of cholinergic atten
uation on the consumption of non-water liquids.

While in this case the

peripheral effects of scopolamine cannot explain the decrease in "food"
reinforced responding, the liquid nature of the reinforcer might relate
to the suppression of the thirst circuit.

Innis and Staddon (1969) also found a loss of timing behavior in
FI responding for a reinforcement of water with sweetened condensed
milk, as well as an apparent decrease in response rate, when scopol
amine (.5 mg/kg) was given.

Methyl scopolamine produced neither the

loss of timing behavior nor the decrease in response rate.

The finding

that central cholinergic attenuation results in a loss of timing be
havior is consistent with the results of other work using FI and DRL
schedules of reinforcement (Carlton, 1963; Boren & Navarro, 1959; Willis
& Windland, 1968).
Boren and Navarro (1959) trained rats on a multiple FR FI schedule
with water reinforcement.

The subjects were then given either atropine

(.1, 1.0, 2.0, or h.O rag/kg) or scopolamine (.1, .2, .h, .8, 1.6, or
3.2 mg/kg).

At high doses, the temporal patterning of both the FR and

the FI components of the multiple schedule was disrupted and changed to
steady responding.
the FI rate did not.

The average FR rate decreased at these doses, though
The FI showed a decreased terminal rate and the

post-reinforcement pause was eliminated.
a

At medium doses the FI changed
■"

temporal pattern, but the FR did not— an indication that the schedules
were differentially sensitive to atropine and scopolamine.

At low

doses which did not alter temporal patterning, there was some evidence
of stimulation in that the average FI and FR rates were increased.
Hanson, Witoslawski, and Campbell (I967 ), using monkeys trained on a
multiple VI (Con FR FR-shock)

schedule, found that scopolamine (.039-

.625 mg/kg) decreased VI responding for sweetened condensed milk, had

minimal effect on the concurrent.schedule component, and increased

8
responding.

The decrease in VI responding was minimal at the lowest

dose used, with response rate an inverse function of the dose magnitude.
Willis and Windland (1968) gave repeated injections of 20 mg/kg atropine
to rats trained to respond for water on either a multiple FR DRL schedule
or a multiple VI FI schedule.

Again, VI responding was decreased, and

repeated administration of the agent had no effect on the response sup
pression.

All injections of atropine also decreased response rates on

the FR schedule.

Response rates were increased on the DRL schedule and

decreased on the FI schedule.

In some of the subjects these effects

diminished on subsequent injections of atropine, suggesting that the
effect of attenuation of central cholinergic activity on those schedule
components (DRL and FI) involving timing behavior decreases with repeated
administration of the anticholinergic agent.
Table 1 summarizes the data from these studies concerning the effects
of dose level and repeated administration of atropine and scopolamine on
liquid-reinforced responding in six operant schedules.

It is readily

apparent that dose level and the number of drug administrations are strong
factors in the effect of cholinergic attenuation on operant responding.
Purpose of the Present Research
Dry food has not been used as a reinforcer in the investigation of the
effects of cholinergic attenuation on operant responding.

The present

study was designed to compare the effect of a relatively low dose (2 rag/kg)
of atropine on VI responding for either food or water reinforcement.
A VI schedule was selected because it offered the advantage of response
stability and a minimum of confounding temporal factors.

This allowed

Table i,

General effects of atropine and scopolamine on response

rate in six liquid-reinforced operant schedules.

(+ indicates rate

increase, 0 indicates no change, and - indicates rate decrease.)

Schedule
Low
VI

O(-)

FI

0 (+)

FR
Sidman
Avoidance

S*

DRL

Dose
Medium

High

Repeated
Administration
Ho change, or
effect may
diminish

-, change in
temporal pattern

-, change in
temporal pattern

Effect may
diminish

O(-)
Effect may
diminish
Effect may
increase or
diminish
Effect may
diminish

10

easy assessment of the differential interaction of food or water rein
forcement with cholinergic attenuation.

While a ratio schedule might

have been chosen, it was felt that the more intermediate rates usually
obtained from short-interval VI responding would be more amenable to
response rate manipulation.
Both atropine sulfate and atropine methyl nitrate were expected to
suppress responding for the dry food pellets, since the peripheral con
sequences (especially the dry mouth and throat) of cholinergic attenua
tion were expected to add an aversive component to the reinforcing
stimulus.

That the suppression is due to the peripheral rather than the

central actions of the drugs was expected to show up in several ways.
First, both atropine sulfate and atropine methyl nitrate should sup
press responding.

Second, atropine methyl nitrate, which has somewhat

greater peripheral activity than the tertiary salt, should suppress
responding to a greater extent than does atropine sulfate,

Finally, since

the central ‘'hunger drive" mechanisms would not be affected by cholin
ergic attenuation, the subjects were expected to begin responding at
*

or about their criterion rate.

"

This rate was then expected to decrease

as a function of the number of reinforcements received.

Thus, a higher

percentage of the total responses was expected to occur during the first
half of the day‘s session, in comparison with a control group.
Water reinforced responding was expected to be minimally affected by
this dose level of atropine.

Some slight reduction in responding was

expected to follow the administration of atropine sulfate (although the
reduction was not expected to be statistically significant), and atropine
methyl nitrate was expected to cause no change in the response rate.

CHAPTER II.

METHOD

Subjects
Forty-two male Long-Evans hooded rats, 90-120 days of age, were
randomly divided into six equal groups.

The subjects were maintained

at 80$ of their estimated growth curves; three groups by controlled
feeding at the end of each day's session, and three by timed access
to water at the end of each day's session.

All subjects were housed

in individual home cages.

The subjects were tested in Lehigh Valley two-bar rat boxes, which
were housed in sound-insulated, ventilated chests.

The left bar and

the cue lights were removed from each box, and their openings covered
with a metal plate set flush with the wall.

Water reinforcements were

delivered by a Lehigh Valley Model 1351 liquid dipper, and food rein
forcements by a Scientific Prototype Model D700 pellet dispenser.

Each

bar required a minimum force of 12 gm in order to activate the electronic
programming equipment, which was housed in a separate room.

Procedure
All subjects were trained to bar-press on an arithmetic VI 30
second (5-55 second range) schedule for either food (9^ mg Noyes pellet)
or water (,04cc, 4 second presentation) reinforcement.

Each subject

was tested for one 16 minute period (32 reinforcements) per day, to a
criterion of either five consecutive days where the response total
fell within + 10$ of the mean response total for the previous five

12

days, or 60 days, whichever came first.

For 10 days following cri

terion, the subjects received i.p. injections of either 1 ml/kg iso
tonic saline (Groups F/S and W/S; that is, food or water reinforcement
with saline injection), 2 mg/kg atropine sulfate in isotonic saline
(Groups F/AS and W/AS), or 2 mg/kg atropine methyl nitrate in iso
tonic saline (Groups F/AMN and W/AMN).
The injections, which were made using a blind procedure (the
experimenter did not know which agent he was injecting into any given
subject), were administered 30 minutes prior to the day's session.
Data were collected on the total number of responses per session,
as well as on the number of responses in the first and second half of
each session.
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CHAPTER III.

RESULTS

Eight subjects were tested for the full 60 days without reaching
the percentage criterion.

Since these were evenly distributed among

the six groups (four groups had one such subject each, and two groups
had two), no special consideration was given to the type of stability
criterion reached.
The data from the first of the 10 drug days were discarded to
avoid confounding by reactions to the injection procedure itself.

The

remaining nine days were grouped into blocks of three, and a suppression
ratio (total responses in each three-day block divided by the total re
sponses for the last three criterion days) was computed for each
subject (Appendix III).

A 2 X 3 X 3 (reinforcement by drug by trial

block, with repeated measures on the trial block factor) factorial anal
ysis of variance was then computed (Table 2).

The reinforcement and

drug factors were significant (p<.01), as were the drug by reinforce
ment and drug by reinforcement by trial block interactions (p<.01),
and the reinforcement by trial block interactions (p <.05). However,
*
'
since the three-way interaction is so complex, and accounts for so
small a/proportion of the total variance (w 2 = .001), no attempt will
be made to deal with it here.
The mean suppression ratio for each group is shown in Fig. 1.

As

predicted, Groups F/AS and F/AMN both show extensive response suppression
(Kruskal-Wallis H = 3^.60, df = 2, p<.00l), while Groups W/AS and W/AMN
did not differ significantly from Group W/S (H = 2.39, df = 2, p>.10).
The difference in suppression between Groups F/AS and F/AMN, while in
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Table 2.

Summary of analysis of variance.

MS

F

1

11.387

123.77**

2.181

2

1.091

11.86**

2.417

2

1.209

13.14**

3.323

36

.092

.195

84

C (Trials)

.011

2

.006

3.00

AC

.017

2

.009

4.50

BC

.014

4

.004

2.00

ABC

.034

4

.009

4.50*

.119

72

.002

Source

SS

df

19.308

41

11.387

B (Drug)
AB

Between S
A (Reinforcement)

^within groups
Within S

0 by
* p < .0 5
* p < .01

groups

*

15

1.00

.90
.80

RATIO

.70

.60

SUPPRESSION

.50

.40
.30
.20
.10

F/S

Fm m

F/AS

W/S

W /AM N

W /AS

DRUG GROUP
Fig. 1.

Mean suppression ratio as a function of drug group.
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the predicted direction, was not statistically significant (H = .339*
df = 1, p > . 50 ).
The mean suppression ratios for the reinforcement by trial block
interactions are shown in Fig, 2.

While the interaction was, as stated

above, significant at p<.01, neither trend was individually significant
(H = 1.6*+, df = 2, p >. 10 for food reinforced subjects and H = 2.39,
df = 2, p>.!0 for the water reinforced subjects).
Finally, the proportion of responses made in the first half of each
drug session was computed for each food reinforced subject (Appendix III),
and the mean proportion for each food group over the last five drug days
was determined (Fig. 3).

While the results for Group F/AMN were in the

predicted direction, the effect was not significant (H = 1.87, df = 2,
p>.25).

SUPPRESSION

R A TIO

17

Block

Block

FOOD
Fig, 2,

Mean suppression ratio:

Slock

Block

B lo ck

1

2

3

WATER
Reinforcement by trial blocks

F/AS

F/S

F/A M N

DRUG GROUP
i Fig. 3.

Mean proportion of responses in

first half of drug session:
subjects.

Food reinforced
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CHAPTER IV.

DISCUSSION

Food Reinforcement
The present results support the previous research showing that both
atropine sulfate and atropine methyl nitrate suppress eating behavior.
The earlier suggestion (Stein, 1963) that this suppression is due to the
peripheral action of the anticholinergic agents receives at best only
minimal support here.

While both agents did suppress food-reinforced

behavior (and atropine methyl nitrate has only minimal central activity—
if any— at this dose level), Group F/AMN did not have a significantly
greater degree of response suppression than did Group F/AS.

Further,

while Group F/AMN did tend to give a greater proportion of its total
responses in the first half of the trial interval than did Group F/S,
Group F/AS gave the least proportion of first-half responses of the three
groups.

Again, however, these differences were not statistically

significant.

Thus, neither hypothesis (that Group F/AMN would show

more suppression of food-reinforced responding than would Group F/AS,
and that both Groups F/AMN and F/AS would give a greater proportion of
*

first-half responses than would Group F/S) was supported by the present
data.

A discussion of the possible implications of the first-half

response data from Group F/AS is given in Appendix IV.
One line of evidence does suggest that the suppressed food rein
forced responding is due to the decreased incentive value of the food
pellets.

Such an explanation is compatible with the tendency for the

subjects in both Group F/AS and Group F/AMN to leave more than 50$ of
the reinforcement pellets they received uneaten (Table 3 ).

Faidherbe,

20

Table 3.

Group

Proportion of nonconsumad reinforcement pellets.

Subject

F/AMN

F/AS

F/S

Note:

3
7
1?
22
25
5
8
16
24
2
6
12
19
21

Mean
Reinforcements
Received
4.6
19.5
2 2 ,0
19.9
13.6
12.0
24.8
2 3 .6
16.4
30.7
25.7
31.1
31.5
31.4

Mean
Proportion
Uneaten
.402
.078
.082
.073
.257
.283
.042
.215
.206
.003
.011
.000
.000
.000

Minimum
Proportion
Uneaten
.000
.000
.000
.000
.000
.000
.000
.000
.000
.000
.000
.000
.000
.000

Maximum
Proportion
Uneaten
1.000
.167
.273
.250
.625
.66 ?
.125
.613
.643
.032
.038
.000
.000
.000

This data had not begun to be collected until several

of the subjects in each group had already been tested.

Nevertheless,

a statistical analysis was performed, and was significant.
p < .01; From Diamond, S.
statistical analysis.

(H = 8 .865 ,

Information and error; An Introduction to

New York:

Basic Books, Inc., 1959, p. 282.)

21

/

Richelle, and Schlag (1962) have explained reinforcement nonconsumption
during methylphenidate action as being due to response perseveration
resulting from the generalized activation generated by this compound.
This explanation might hold for the nonconsumption of reinforcement by
Group F/AS as well, since atropine sulfate and scopolamine do lead to
response perseveration (Hearst, 1959; Carlton, 1961).

However, response

perseveration will not serve as an explanation for the nonconsumption
of reinforcement t»y Group F/AMN.

Another explanation, that the periph

eral action of both atropine sulfate and atropine methyl nitrate made
eating of the dry food pellets aversive, might better be able to deal
with the present results.

In this case, a large number of secondary

reinforcers, including the sound of the pellet dispenser and the sight
of the pellets, as well as the general environmental stimuli, would serve
to maintain responding— although at a lower rate.

Water Reinforcement
Suppression of water responding was not found for either Group W/AS
or Group W/AMN, a result which is in accord with previous work (Stein,
1963 )» and is consistent with the suggestion that the effects of cholin

ergic attenuation on thirst-related behavior is dependent upon the
amount of the anticholinergic agent given.
It is quite likely that the degree of suppression is not a simple
function of the degree of central cholinergic attenuation.

If this

were the case, there would have been some suppression for Group W/AS,
since it has been demonstrated that atropine sulfate is active centrally

at the dose level used— both in terms of behavioral measures in rats
and monkeys (Samuel, Kodama, & Mennear, 1965; Whitehouse, 1964, 1967;
Whitehouse, Lloyd, & Fifer, 1964) and as measured by EEG changes in
cats (Torii & Wikler, 1966).

The amount of response suppression is

more likely to be a complex function of the central attenuation in re
lation to the amount of anticholinergically-induced peripheral feedback.
This feedback would serve to activate central mechanisms which through
their activity allow the central thirst system to operate even though
one or more of its components are partially blocked.

Since atropine

works by competitive antagonism (Goodman and Gilman, 1965 ), the degree
of attenuation can be overcome by increasing the amount of acetylcholine
available at the receptor membrane.

Increased peripheral feedback can,

by increased stimulation of the presynaptic membrane, cause the release
of an increased amount of acetylcholine at the synapse, thereby allowing
the system to operate in the presence of a relatively small amount of
atropine.

As the dose level increases, the degree of central attenuation

(or the amount of atropine available at the synapse) should become great
enough that the increased peripheral feedback Would have minimal effect,
and thirst-related behavior would show maximal suppression.
Proposed Research
Several lines of research are suggested by the present study.

First,

of course, would be an investigation of the role played by peripheral
feedback in the central suppression of thirst-related behavior.
question can be approached in at least two ways.

This

The amount of peripheral

23

feedback occuring prior to the administration of the anticholinergic
agent can be varied by the manipulation of the deprivation state.

For

a given dose magnitude, it would be expected that the degree of sup
pression would be inversely related to the degree of deprivation.
Further, this relationship would diminish as the dose magnitude increases,
until at some relatively high dose magnitude suppression would be at its
maximum, with the degree of deprivation having little effect on the
degree of suppression.

Another approach would be to vary the amount of

drug-induced peripheral feedback for a given deprivation state.

For

instance, dose equivalence on several independent measures of central
activity might be determined for atropine sulfate and trihexyphenidyl.
It is then possible that a dose level of trihexyphenidyl might then be
expected to cause greater suppression of thirst-related behavior than
the centrally equivalent dose of atropine sulfate, because of the lesser
degree of salivary inhibition caused by the former agent.
Another line of research might involve the study of the role of the
peripheral consequences of a pharmacological agent on the nonconsumption
of reinforcement.

The suggestion is that the agent might act periph

erally to increase or decrease the palatability (textural, gustatory,
or even olfactory) of the reinforcer, and thereby affect responding for
that reinforcer in a way ■unrelated to the central activity of that agent.
It would be, therefore, appropriate for the experimenter, before applying
a behavioral test of central activity, to determine if the agent acts
to change the reinforcing properties of the reinforcer selected.

This

can be tested in a number of ways, including ad lib consumption compared
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with non-drug baselines, changes in selection preferences (although
here the effect on the alternative selection must be considered), and
changes in response rate for the reinforcer on the task which has been
shown to be unaffected by the central action of the agent to be employed.
A final avenue of research, related to the question of incentive
value changes, is the question of the type of incentive offered by
sweetened condensed milk— regardless of the type of deprivation
schedule employed.

The data from the Hanson, Witoslawski, and Campbell

(1967) study showing a VI response decrease on the administration of
scopolamine when this liquid is used as reinforcement for food-deprived
monkeys, suggests that in spite of the "food" characteristics of the
reinforcsr and the food deprivation, inhibition of the thirst system
by cholinergic attenuation may have served to suppress responding for it
in the same way that such attenuation suppresses water reinforced respond
ing.

If this is the case, then textural (and other peripheral) qualities

of the reinforcsr must be considered as well as those qualities it holds
in relation to the deprivation conditions employed whenever a behavioral
*
-r*'
test- of drug action is to be employed.
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CHAPTER V.

SUMMARY

Forty-two male Long-Evans hooded rats were trained to bar-press on
a VI 30 second schedule for either water (three groups of seven rats) or
food (three groups of seven rats) reinforcement.

Following the attain

ment of a stability criterion, all subjects received i.p. injections of
either 2 mg/kg atropine sulfate, 2 mg/kg atropine methyl nitrate, or 2
ml/kg isotonic saline.

Each subject received a total of 10 injections,

which were given using a blind procedure.
A 2 X 3 X 3 (reinforcement by drug by trial block, with repeated
measures on the trial blocks factor) analysis of variance was computed
using the mean suppression ratio determined for each group.

The rein

forcement and drug factors, and the drug by reinforcement and the drug
by reinforcement by trial blocks interactions, were all significant at
p<,01.

The reinforcement by trial blocks interaction was significant

at p <.05.
Further analysis of the data showed that both atropine sulfate and
atropine methyl nitrate suppressed VI responding for food reinforcement.
.a

“

Some support for the suggestion that this suppression was due to the
peripheral actions of the drugs was obtained from the nonconsumption of
a large proportion of the reinforcement pellets t>y the test subjects.
Neither agent had a significant effect on water-reinforced responding.
It was suggested that suppression of thirst-related behavior by anti
cholinergic substances is a dose-related function of both the central and
the peripheral consequences of cholinergic attenuation.
In the light of the present results, several further avenues of
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research were recommended.

First, the role of peripheral feedback in the

central suppression of thirst-related behavior could be investigated by
manipulating either the deprivation state or the amount of drug-induced
peripheral feedback.

Second, the role of the peripheral consequences of

drug administration on reinforcement nonconsumption might be investigated
across a wide spectrum of reinforcements and of pharmacological agents.
Finally, it was suggested that central cholinergic attenuation may suppress
responding for sweetened condensed milk, in spite of its use as a "food'1
reinforcer, because of its liquid nature.
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APPENDIX I.

THE PHARMACOLOGY OF ATROPINE AND SCOPOLAMINE

Chemistry, Mechanism, and Specificity of Action

Atropine and scopolamine inhibit the action of acetylcholine on
structures innervated by postganglionic cholinergic nerves and on smooth
muscles that respond to acetylcholine but lack cholinergic innervation.
They are, therefore, known as antimuscarinic agents,

Antimuscarinic

agents have considerably less effect on the action of acetylcholine at
other sites, although high doses of atropine can block transmission at
autonomic ganglia and at skeletal neuromuscular junctions.

These agents

are also active in the central nervous system.
Figure 4 shows the structural formulas of atropine and scopolamine,
which are esters formed by the combination of an aromatic acid (tropic
acid) and an organic base, either tropine or scopine,

Scopine differs

from tropine only in having an oxygen bridge between carbon atoms 6 and
7 of the base.

This oxygen bridge is the sole difference between atropine

and scopolamine.
Atropine and scopolamine act through a competitive antagonism to
acetylcholine and other muscarinic agents (Goodman & Gilman, 1965).

This

antagonism is surmountable by increasing the concentration of acetyl
choline at the receptor sites of the effector organ.

As stated above,

these agents act at the cholinergic receptor sites of those peripheral
structures either stimulated or inhibited by muscarine (including
exocrine glands, smooth muscle, and cardiac muscle), as well as in the
central nervous system.
Atropine is highly selective as an antagonist of muscarinic agents—
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so much so that atropine blockade of the action of other types of drugs
has been taken as evidence that they act through cholinergic mechanisms
(Goodman & Gilman, 1965).

This specificity of action is lost, however,

at high doses, where atropine may inhibit responses to histamine, 5-HT,
and norepinephrine.

Also, atropine-induced parasympathetic block may be

preceded by a brief phase of mild stimulation.

This is especially noticed

in the heart, where a brief bradycardia (probably due to central action)
may precede the peripherally-induced tachycardia.

Furthermore, it has

been suggested (Averill & Lamb, 1959; Ashford, Penn, & Ross, 1962) that
low concentrations of atropine may also directly stimulate isolated tissue.

Pharmacological Actions (Central)

In the central nervous system, atropine stimulates the medulla and
higher cerebral centers.

At clinical doses (.5-1.0 mg in humans), this

effect is usually confined to a mild vagal stimulation.

At toxic doses

of atropine central excitation becomes more prominent, with symptoms of
restlessness, irritability, disorientation, hallucinations, or delirium.
With still higher doses, stimulation is followed by depression and med
ullary paralysis, resulting in death.

Scopolamine, at therapeutic doses,

produces drowsiness, euphoria, fatigue, and dreamless sleep.

Both agents

have been used in the treatment of parkinsonism, and scopolamine has been
found to have ten times the potency of atropine in the alleviation of
postural tremor in monkeys with subthalamic or midbrain reticular lesions
(Vernier & Unna, 1956).
In general, atropine acts to decrease EEG activity in man and lower
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animals.

Drowsiness and flattening of EEG with disappearance of alpha

activity has been found in humans at doses of atropine from 1.95 to
9.75 ®g (White, Rinaldi, & Himwich, 1956).

Dogs given atropine show

high voltage slow waves and spindle burst EEG activity regardless of
whether the animals were lying quietly with their eyes closed or were
moving about (Wikler, 1952)»

This phenomenon, known as dissociation,

has also been observed in cats and rabbits (Bradley & Elkes, 1953* 1957*
Bach, Kelly, & Staub, 1955* Longo, 1956; Chow, Dement, & Mitchell, 1959).
Atropine has also been shown to decrease electroeortical "arousal" re
sponses elicited by either sensory stimulation or by stimulation of the
midbrain reticular formation (Rinaldi

& Himwich, 1955* Bradley & Key,

1958* Paul, Riehl, & Unna, 1959) without affecting the behavioral
response to such stimulation.

Ostfeld, Machne, and Unne (i960) found

that atropine (4.5 and 6.75 mg) caused a pulse rate increase of 60$,
saliva volume decrease of 68$, and duration Of EEG arousal response to
both single and repetitive light flashes decrease of 50$.

A decrease

in spontaneous speech movement, decrease in memory and attention, and
f
t

increased drowsiness were also found.

The spontaneous EEG showed a

consistent shift toward lower amplitude and slow activity, with the
alpha index decreased by 60 percent.

They concluded that the decreased

EEG arousal response could be attributed to the action of atropine on
the ARAS, which occurred simultaneously with and independently of the
effects which modify the spontaneous EEG rhythm.
Antagonism by atropine of many of the central effects of acetyl
choline, eserine, and diisopropyl fluorophosphate is a part of the
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indirect evidence that acetylcholine may act as a chemical mediator
in the brain.

While it is not known whether the observed effects

on the central nervous system are due to direct actions on neurons
or to antagonism of a central synaptic transmitter, the fact that
scopolamine and atropine induced suppression of the cat reticular
activating system can be blocked by a cholinesterase inhibitor,
eserine, (Exley, Fleming, and Espelien, 1958) further supports the
latter interpretation.

Pharmacological Actions (Peripheral)
In the eye, atropine and scopolamine block the responses of the
ciliary muscle of the lens and the sphincter muscle of the iris to
cholinergic stimulation.

The pupils are dilated (mydriasis) and

there is paralysis of accomodation (cycloplegia).

The ocular effects

develop more slowly after subcutaneous injection, and last longer than
do the effects on salivary secretion and respiration.

It has been

suggested (Herxheimer, 1958) that a reservoir, perhaps the aqueous
humor, accumulates the agent and later releases it to the iris and
ciliary muscles.

While atropine and scopolamine have little effect on

intraocular pressure, they do elevate intraocular pressure when it is
initially above normal (as in glaucoma).
Atropine and scopolamine are often used in preanesthetic medication
because of their action on the respiratory tract.

There, they inhibit

secretions of the nose, mouth, pharynx, and bronchi (and thus dry the
mucous membranes of .the tract), and relax the smooth muscles of the
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bronchi and bronchioles.

Atropine is more potent than scopolamine in

this latter action (Goodman & Gilman, 1965).
The main effect of atropine on the heart is to alter the rate.
With average clinical doses the rate may be temporarily decreased.

This

decrease is never great, and there are no changes in blood pressure or
cardiac output.

Larger doses cause progressively increasing tachycardia,

although the maximal heart rate is not affected.

The main change produced

by 1.2 mg of atropine in the human ECG is in a significant lowering of
the T waves (Nickerson & Smith, 19^9).
In the gastrointestinal tract, atropine and scopolamine can com
pletely abolish the profuse, watery parasympathetically-induced salivary
secretion.

The mouth becomes dry, and swallowing becomes difficult

(Ambach, 1955? Bachrach, 1958)*

Relatively large doses can reduce gas

tric secretion both in volume and total acid content, an effect that is
especially noticable in dogs.

Therapeutic doses of atropine produce

prolonged inhibition of the motor activity of the stomach, small intestine,
and colon.

This inhibition is characterized by a decrease in tone and a
*

-—

"

decrease in the amplitude and frequency of peristaltic contractions
(Goodman & Gilman, 1965).
In man, atropine (1.2 mg) has many effects on the urinary tract.
It dilates the pelvis, calyx, ureters, and bladder, and increases the
visibility of the kidneys.

Atropine also shows incomplete blockade of

the motor response of the bladder to injected choline esters or to
parasympathetic nerve stimulation.
Small doses of atropine or scopolamine inhibit sweat gland activity
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in humans, causing the skin to become hot and dry.

At higher doses,

this inhibition may be great enough to cause a significant rise in
body temperature.

While it is possible that this rise in body tem

perature may be due to a central action on temperature regulators,
animals which do not sweat, such as dogs, do not show a rise in body
temperature following atropine administration (Goodman & Gilman, 1965).
This suggests that the temperature change is indeed a result of the
sweating inhibition.
Tolerance, Absorption, Fate, and Excretion
Tolerance to atropine and scopolamine occurs in man to some extent.
This is especially noticed in patients with parkinsonism, who may take
daily doses of atropine or scopolamine that, if given in a first admin
istration, would result in poisoning.

While habituation and addiction

do not occur, vomiting, sweating, and salivation have been found in
parkinsonism patients when their large therapeutic doses are suddenly
withdrawn (Goodman & Gilman, 1965 ).
Atropine and scopolamine are rapidly absorbed from the gastrointes
tinal tract, and are also absorbed from the other mucosal surfaces of
the body.

Atropine is rapidly taken up from the blood and is distrib

uted throughout the body.

Much of the agent is destroyed in the liver

by enzymatic hydrolysis, and some is excreted unchanged in the urine.
However, the amount so excreted in man is unclear, ranging from 13$
after lh hours (Tonneson, 1950)♦ to 50$ after 2h hours (Gosselin,
Gabourel, & Wills, i 960).

This excretion of unchanged atropine and
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scopolamine makes recognition of their presence in the system possible
by a simple, rapid, and presumptive test,

A drop of urine in the eye of

a cat will cause dilation of the pupil if it contains even a small
amount of atropine or scopolamine (Goodman & Gilman, 1965),
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APPENDIX II. THE ROLE OF THE CEREBRAL VENTRICLES
IN THE CHEMICAL MEDIATION OF THIRST

It has recently been suggested that at least a part of the effect
on drinking by carbachol may be mediated through the cerebral ventri
cles— either by general modification of the milieu of the ventricles
or by stimilation of certain (unspecified) receptors that may line
the walls of the ventricles.

Routtenberg (196?) cites several argue-

ments in favor of this hypothesis.

First, the data indicates that

structures showing carbachol-induced drinking lie close to the midline,
with increasing lateral distance correlated with decreased effective
ness.

Second, carbachol applied to the fornix causes drinking.

This

would be difficult to interpret if the carbachol is thought to act at
synaptic sites.

Third, chemical stimulation of the septum elicits

drinking, an effect which is also brought about by septal lesions.
The proximity of the third and lateral ventricles to the limbic
system, which is so widely represented in the thirst system, is cited
as indirect evidence in support of the ventricular modification hypoth
esis.

Finally, the hypothalamic areas indicated by Grossman (i960 )

that induce drinking following carbachol application lie close to the
ventricles and are typically medial and dorsal to those hypothalamic
areas found by Anand (1961) to cause adipsia when lesioned.

Routtenberg

feels that this indicates that the results might better be explained by
diffusion of the test agents into the cerebral ventricles, where they
exert their effect.
Support for this hypothesis has been minimal, however.

Levitt (196?)
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cites four additional lines of evidence in favor of Routtenberg*s
hypothesis.

First, drinking has not as yet been successfully

triggered in rats by electrical stimulation of most of the limbic
sites'where a cholinergic stimulus has been successful.

Second, the

minimal drinking latency after localized brain injections is about
three seconds (and is often longer), a result that is easily explained
if diffusion to a distant site is postulated.

Third, unless diffusion

to a distant site is postulated, it is hard to explain the fact that
atropine blocks cholinergically-induced thirst when applied to a posi
tive contralateral site.

Finally, Fisher and Levitt (unpublished)

have found that carbachol can induce drinking when placed in the
ventricles, and ventricular atropine can successfully block cholinergic
induction of drinking at other sites.

Thus cholinergic agents and

their inhibitors can act either within the ventricles or by diffusion
from the ventricular spaces to influence tissue involved in the media
tion of drinking behavior.

However, data from sites close to but not

within the posterior horn of the lateral ventricle, as well as from
*

injection into negative hippocampal areas, have failed to show drinking
following normal or reduced cholinergic stimulation.

Furthermore, it

would be difficult for ventricular mediation to serve as the explaination
for the drinking following cholinergic stimulation of the cingulate
cortex.

The thickest portion of the corpus callosum overlays access to

ventricular spaces in this region, and Feldberg (1963) has reported that
diffusion through white matter is often slow or negligible.
Meyers and Cicero (1968) failed to obtain significant changes in

3?

water intake in excess of baseline levels by intraventricular microinjections of five dose levels of carbachol.

Khavari, Hesbink, and

Traupman (1968) replicated this result, and further found that eserine,
an anticholinesterase found by Miller (1965 ) to increase drinking when
injected into the preoptic region of slightly water deprived rats, failed
to induce drinking when given intraventricularly.

Indeed, the highest

dose used (4.0/4g) brought about a decrease in drinking— an effect which
may be related to drug toxicity at that dose level.
Finally, Mountford (1969) found that direct application of carbachol
to the rat hippocampus resulted in greater increases in drinking than
did similar applications to the adjacent lateral ventricles.

This result

is in contradiction to the hypothesis that drinking modifications are the
result of diffusion by the test chemicals to active sites in or near the
cerebral ventricles.

Thus, the question of the role played by the cerebral ventricles in
this circuit is as yet unresolved, although the weight of the evidence
lies strongly in favor of a structural circuit rather than action by
*

diffusion into the ventricles.

—

-
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APPENDIX III.

RAW DATA

Total Responses: Criterion and Drug Blocks

Group

F/S

F/AMN

F/AS

W/S

W/AMN

W/AS

Sub.iect
2
6
10
12
15
19
21
3
7
11
14
17
22
25
5
8
9
16
18
20
24
29
38
42
43
45 ^
47 i
27
28
35
37
40
44
51
48
30
34
39
41
46
50
26

Criterion
Block 1
1481
404?
1365
253
1206
1709
4098
5838
2004
1947
2326
2992
3679
3879
21
3765
3892
56
234
2692
137
1559
192
3209
2654
95
111
1532....
48
1133
870
206
931
25
5022
1092
60
873
3394
27
4416
. ... 865
2198
2419
1070
927
420
549
688
1044
1803
1927
1979
1751
605
537 .
1596
1675
964
872
2798
2449
1814
2013
2023
2092
2132
3478
2318
1319
975
1313
646
521
884
952
827
1037
686
592
1328
1010
1376
823-

Block 2
738
215
1205
4769
2269
2607
3200
7
263
208
9
383
97
299
60
284
7
867
113
111
61
1909
838
430
605
I892
2130
486
1665
1216
2001
1978
2309
2209
958
1231
470
1049
884
694
1308
1046

Block 3
845
223
1463
4892
1776
1752
2696
37
127
27
121
320
197
83
38
81
3
391
274
70
409
1884
898
494
835
1976
1868
__
508
1638
804
2004
2017
2033
2481
1589
1255
401
968
923
656
1308
.....m
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Suppression Ratios: Sub.jects by Trial Bloeks

Group

F/S

f /a m n

F/AS

W/S

W/AMN

W/AS

Subject
2
6
10
12
15
19
21
3
7
11
14
17
22
25
5
8
9
16
18
20
24
29
38
42
43
45
47
27
28 >
35
37
40
44
51
48
30
34
39
41
46
50
26

Trial Block 1
.366
.185
.706
.702
1.029
.777
.948
.006
.014
.087
.088
.060
.036
.072
.042
.237
.027
.217
.069
.008
.196
.909
.866
.765
.659
1.069
.885
.888
.953
.905
1.143
.901
.967
.613
.569..
.743
.807
.929
.797
1.159
.761
.598

Trial Block 2
.182
.158
.705
.817
I.I65
.871
.825
.002
.068
.077
.006
.119
.037
.195...
.053
.326
.008
.173
.129
.033
.014
.789
.783
.783
.580
1.049
1.076
.803
.994
1.261
..817
.983
1.104
.635
.... .413 _ _
.938
.728
1.102
.852
1.172
.985
.760

Trial Block 3
.2 0 9
.163
.856
.838
.912
.586
.695
.010
.033
.010
.078
.100
.074
.054
.034
.093
.003
.078
.314
.021
.093
.779
.839
.900
.800
1.096
.944
.840
.978
.834
.818
1.002
.972
.713
.686
.95^
.621
1.017
.890
1.108
.985
.694

Proportion of Responses in First Half of Drug Session:
Food Reinforced Subjects

Group

F/S

F/AMN

F/AS

Sub.iect
2
6
10
12
15
19
21
3
7
11
14
17
22
25
5
8
9
16
18
20
24

Percent
.561
.648
.509
•453
.382
.438
.447
.881
.467
.355
.266
.892
.744
.500
.319
.520
.125
.698
.493
.693
_,163
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APPENDIX IV.

ATROPINE SULFATE AND FIRST-HALF RESPONDING

While the results concerning first-half responding were not statis
tically significant, the data for Group F/AS merit some discussion in
the light of recent data on the effect of cholinergic attenuation on
habituation.

Carlton (1963, 1968) and Carlton and Vogel (1965, 1967)

have demonstrated that central cholinergic attenuation results in the
suppression of habituation, a conclusion which has been supported by
Leaton (1968) using an exploratory incentive as the reinforcement for
position discrimination in a T-maze.

Subjects given scopolamine prior

to training trials learned to enter the exploratory-reinforced (by junk
objects) arm 100$ of the time, and learned to reverse this preference
when the reinforced arm was reversed.

Saline controls consistently

chose the exploratory arm about 60$ of the time, a choice preference
that was maintained upon reversal.

The lower preference for the explor

atory aim on the part of the controls might be explained as being due
to a decreased incentive value resulting from habituation in that arm.
The present^ experiment may also offer some opportunity for this
suppression of habituation to take place.

If warm-up decrement (the

decreased response rate often seen at the beginning of a free operant
session) can be thought of as a brief period of habituation during which
exploratory responses compete in strength with the desired operant
response— and observation of the subjects suggests that this is the case—
then atropine sulfate should extend this period of decreased lever
responding, and Group F/AS would be expected to give a proportionately
fewer number of lever responses during the first half of the session
than either of the other groups.
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